Polygenic Risk Score as a Predictor of Bone Fracture or Osteoporosis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy [0.03%]
多基因风险评分作为接受雄激素剥夺治疗的前列腺癌患者骨折或骨质疏松症预测因子的影响研究
Ying-Qiang Liu,Li-Wen Chang,Hui-Wen Yang et al.
Ying-Qiang Liu et al.
Background: The association between single nucleotide polymorphisms (SNPs) and fracture risk has been established in various studies. Androgen-deprivation therapy (ADT) for prostate cancer, while extending survival, incre...
Oncotype Dx Breast Cancer Assay in Older Patients: A Real Life Cohort [0.03%]
老年患者Oncotype DX乳腺癌检测的真实世界队列研究
Clément Grosnon,Lauren Seknazi,Djamel Ghebriou et al.
Clément Grosnon et al.
Introduction: The Oncotype DX Breast Recurrence Score test was designed for HR+, HER2- early breast cancer (eBC) to assist in the decision-making process for de-escalating adjuvant chemotherapy (CT). Its validity and util...
Kazuki Fukuzawa,Yoshimitsu Shimomura,Ling Zha et al.
Kazuki Fukuzawa et al.
Background: Patients with lung cancer tend to have a high incidence of arterial thromboembolism (ATE). However, although ATE is a life-threatening disease, there are insufficient studies evaluating patient characteristics...
An Integrated Clinical-Radiomics-Deep Learning Model Based on 18F-FDG PET/CT for Predicting EGFR Mutation Status in Lung Adenocarcinoma [0.03%]
基于18F-FDG PET/CT的综合临床-影像组学-深度学习模型预测肺腺癌EGFR突变状态
Yun Wang,Zhaoqing Chen,Jing Li et al.
Yun Wang et al.
Background: An integrated model combining clinical variables, radiomic features, and deep learning was developed to predict EGFR mutation status in patients with lung adenocarcinoma based on pretreatment 18F-FDG PET/CT im...
Sexual Orientation and Gender Identity Data in Oncology: Thematic Analysis From a National Qualitative Interview Study [0.03%]
肿瘤学中的性取向和性别认同数据：一项全国定性访谈研究的主题分析
Beck Gold,Dana Rosenberg,Megan A Mullins et al.
Beck Gold et al.
Importance: Sexual orientation and gender identity (SOGI) data are vital, but inconsistently collected among cancer centers. Objective: ...
Second Cancer Incidence and Cause-Specific Mortality in Primary Gastrointestinal Non-Hodgkin Lymphoma Survivors: A Population-Based Cohort Study [0.03%]
胃肠道非霍奇金淋巴瘤幸存者第二原发癌症发病率和病死率的队列研究
Jiahe Wu,Jiangping Yang,Yuxi Ding et al.
Jiahe Wu et al.
Background: Therapeutic advances in primary gastrointestinal non-Hodgkin lymphoma (PGI-NHL) have improved patient prognosis but also raised concerns regarding long-term health outcomes. This study assesses patterns of sec...
CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism [0.03%]
CDH11通过调节线粒体能量代谢促进膀胱癌进展
Osuke Arai,Yuta Yanagihara,Haruna Arai et al.
Osuke Arai et al.
Background: Approximately 83,000 new cases of bladder cancer (BC) in the United States and 23,000 in Japan are confirmed per year, and the number of new BC cases increases every year. While the prognosis for localized can...
Retrospective Analysis of the Association Between Sarcopenia and Fall Risk in Older Breast Cancer Patients Using Real World Data (TriNetX) [0.03%]
使用真实世界数据（TriNetX）回顾性分析老年乳腺癌患者肌肉减少症与跌倒风险之间的关联
Asmaa Namoos,Rana Ramadan,Dina Ramadan et al.
Asmaa Namoos et al.
Background: Falls are a major source of morbidity in older adults and may be particularly consequential for breast cancer survivors, who face vulnerabilities from aging, treatment side effects, and comorbidities. Sarcopen...
Management and Prognostic Implications of Posteriorly Advanced OSCC in Contact With the Medial Pterygoid Muscle [0.03%]
与翼内肌接触的后部进展性口腔鳞癌的管理及预后意义
Nanako Ito,Fumitaka Obayashi,Mirai Higaki et al.
Nanako Ito et al.
Background: T4b was previously defined as unresectable; however, it has been demonstrated that compartmental surgery can achieve treatment outcomes comparable to those of T4a cases. We frequently encounter posteriorly adv...
Integrating Nature Into Oncology: Enhancing Hematological Malignancies Therapies With Natural Medicine [0.03%]
融入肿瘤学的自然疗法：用自然医学改善血液恶性肿瘤治疗
Yaoyao Tian,Baoyi Ni,Dandan Cai et al.
Yaoyao Tian et al.
Hematological malignancies are complex clonal disorders that pose a significant threat to human health. Current treatment modalities, including radiotherapy, chemotherapy, immunotherapy, and bone marrow transplantation, have demonstrated ef...